Relationships between serum osteocalcin versus serum glucose and lipids levels and atherosclerosis in type 2 diabetes mellitus
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000002034
- Lead Sponsor
- Internal Medicine 1, Shimane University Faculty of Medicine
- Brief Summary
Serum osteocalcin levels are associated with glucose and lipid metabolism as well as atherosclerosis in type 2 diabetes mellitus
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Nobody had hepatic or renal dysfunction or nutritional derangements.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method whether or not the signifiant relationships between serum osteocalcin versus serum glucose and lipids levels and atherosclerosis are found
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link osteocalcin to glucose and lipid metabolism in type 2 diabetes mellitus?
How does serum osteocalcin compare to standard biomarkers in predicting atherosclerosis progression in type 2 diabetes?
Are there specific drug targets modulated by osteocalcin that affect atherosclerosis in diabetic patients?
What adverse events are associated with osteocalcin-based therapies for type 2 diabetes and atherosclerosis?
How effective are osteocalcin interventions compared to GLP-1 receptor agonists in managing metabolic syndrome and atherosclerosis?